Status:

TERMINATED

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Lead Sponsor:

Geriatric Oncology Consortium

Collaborating Sponsors:

Sanofi

Conditions:

Colorectal Cancer

Neoplasm Metastasis

Eligibility:

All Genders

65+ years

Phase:

PHASE2

Brief Summary

Currently there is no one standard of care for older patients with metastatic colorectal cancer. The study will examine the tumor response to capecitabine, oxaliplatin, plus bevacizumab. The study wil...

Detailed Description

Colorectal cancer is primarily a disease of the elderly, with the median age in the United States of 70 years. Age greater than 65 years at presentation is not a contraindication to standard therapies...

Eligibility Criteria

Inclusion

  • Age 65 years and above;
  • Histologically or cytologically documented adenocarcinoma of the colon or rectum;
  • Metastatic disease;
  • Measurable disease or assessable but nonmeasurable disease allowed;
  • ECOG 0-1
  • No prior oxaliplatin or bevacizumab.
  • No prior chemotherapy for metastatic disease. Prior adjuvant chemotherapy allowed;
  • No prior fluoropyrimidine therapy (unless give in an adjuvant setting and completed at least 4 months earlier);
  • No bleeding diathesis or coagulopathy
  • Adequate renal and hepatic functions as per protocol;
  • Signed informed consent

Exclusion

  • Clinically significant cardiovascular or peripheral vascular disease;
  • Concurrent chronic aspirin, nonsteroidal anti-inflammatory drugs, warfarin, or therapeutic heparin;
  • Serious non-healing wound, ulcer, or bone fracture;

Key Trial Info

Start Date :

May 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2006

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00120172

Start Date

May 1 2005

End Date

June 1 2006

Last Update

November 16 2007

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Mission Hills, California, United States, 91345

2

Washington D.C., District of Columbia, United States, 20007

3

Inverness, Florida, United States, 34452

4

New Port Richey, Florida, United States, 34652

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer | DecenTrialz